tailieunhanh - BRCA2 carriers with male breast cancer show elevated tumour methylation

Male breast cancer (MBC) represents a poorly characterised group of tumours, the management of which is largely based on practices established for female breast cancer. However, recent studies demonstrate biological and molecular differences likely to impact on tumour behaviour and therefore patient outcome. | BRCA2 carriers with male breast cancer show elevated tumour methylation

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN